Pipecolic Acid

Pipecolic Acid

SCHEMBL9752502

CC(C)(C)OC(=O)N1CCCC[C@H]1C(=O)O.O=C(O)[C@@H]1CCCCN1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.46
RAB9A P51151 1/20 0.41
NPC1 O15118 1/20 0.41
LMNA P02545 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CYP2C19 P33261 1/20 0.39
ALDH1A1 P00352 1/20 0.39
UCHL1 P09936 3/20 0.38
USP30 Q70CQ3 2/20 0.37
EPHX2 P34913 1/20 0.37
HSD11B1 P28845 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Proline SCHEMBL6590813 0.94 HSD17B10 (0.55) HSD17B10SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL65490 0.87 HSD17B10 (0.63) HSD17B10SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL65491 0.87 HSD17B10 (0.63) HSD17B10SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL77858 0.87 HSD17B10 (0.63) HSD17B10SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL222955 0.85 HSD17B10 (0.62) HSD17B10SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL5898691 0.85 HSD17B10 (0.62) HSD17B10SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL18358031 0.85 HSD17B10 (0.62) HSD17B10SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL6219872 0.82 HSD17B10 (0.69) HSD17B10SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL85536 0.82 HSD17B10 (0.69) HSD17B10SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL67045 0.82 HSD17B10 (0.69) HSD17B10SMN1; SMN2RAB9ANPC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991000724-A1 ALKYNYL AMINES THAT REGULATE CHOLINERGIC NEUROTRANSMISSION ABBOTT LABORATORIES (US) 1991-01-24 WO disclosed